Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Pharma
Trial results set up BioMarin for expansion of Voxzogo
With phase 3 results that have “exceeded” its expectations, BioMarin looks set up to gain a label expansion for dwarfism drug Voxzogo.
Kevin Dunleavy
May 21, 2026 10:23am
Fierce Biotech
Strand Tx CEO Jake Becraft weighs in on FDA's IND reform, China
May 4, 2026 12:00pm
FDA's Makary shares policy requests with Congress
Apr 7, 2026 11:04am
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
BioMarin halts dosing, enrollment in 3 midstage Voxzogo studies
Mar 16, 2026 11:26am
Safety signals prompt Ipsen to withdraw cancer med Tazverik
Mar 9, 2026 10:07am
